Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8141)
All Articles published online
|
Publishing Process of This Article
|
Jun 15, 2014 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kitada M, Kanasaki K, Koya D. Clinical therapeutic strategies for early stage of diabetic kidney disease. World J Diabetes 2014; 5(3): 342-356 [PMID: 24936255 DOI: 10.4239/wjd.v5.i3.342] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v5/i3/342.htm |
| Number | Citing Articles |
| 1 |
Peng Liu, Yingying Chen, Bin Wang, Fengmei Zhang, Debao Wang, Yangang Wang. Allopurinol treatment improves renal function in patients with type 2 diabetes and asymptomatic hyperuricemia: 3‐year randomized parallel‐controlled study. Clinical Endocrinology 2015; 83(4): 475 doi: 10.1111/cen.12673
|
| 2 |
Yuka Kotake, Shigehiro Karashima, Masaki Kawakami, Satoshi Hara, Daisuke Aono, Seigo Konishi, Mitsuhiro Kometani, Hiroyuki Mori, Yoshiyu Takeda, Takashi Yoneda, Hidetaka Nambo, Kenji Furukawa. Impact of salt intake on urinary albumin excretion in patients with type 2 diabetic nephropathy: a retrospective cohort study based on a generalized additive model. Endocrine Journal 2022; 69(5): 577 doi: 10.1507/endocrj.EJ21-0447
|
| 3 |
Takeshi Osonoi, Miyoko Saito, Naoya Koda, Satako Douguchi, Takako Nakano, Kensuke Ofuchi, Makoto Katoh. <p>Add-On Therapy with DPP-4 Inhibitors May Improve Renal Function Decline in α-Glucosidase Inhibitor and Metformin Users: A Retrospective Observational Study</p>. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020; : 3497 doi: 10.2147/DMSO.S273405
|
| 4 |
Elaine Cristina Santa Cruz de Moura, Jefferson Belarmino Nunes Barbosa, Patrícia Érika de Melo Marinho. Knowledge regarding the prevention of chronic kidney disease in hypertensive and diabetic patients: a cross-sectional study. Fisioterapia em Movimento 2017; 30(suppl 1): 55 doi: 10.1590/1980-5918.030.s01.ao05
|
| 5 |
Daisuke Koya. 1. Diagnosis and Therapy for Diabetic Kidney Disease-up to Date. Nihon Naika Gakkai Zasshi 2023; 112(3): 432 doi: 10.2169/naika.112.432
|
| 6 |
Takeshi Osonoi, Miyoko Saito, Yusuke Osonoi, Satako Douguchi, Kensuke Ofuchi, Makoto Katoh. Liraglutide Improves Estimated Glomerular Filtration Rate Slopes in Patients with Chronic Kidney Disease and Type 2 Diabetes: A 7-Year Retrospective Analysis. Diabetes Technology & Therapeutics 2020; 22(11): 828 doi: 10.1089/dia.2020.0070
|
| 7 |
Yan Li, Keyang Xu, Kechen Xu, Sixiang Chen, Yifang Cao, Huakui Zhan. Roles of Identified Long Noncoding RNA in Diabetic Nephropathy. Journal of Diabetes Research 2019; 2019: 1 doi: 10.1155/2019/5383010
|
| 8 |
Margarita Saiz Satjes, Francisco J Martinez-Martin. Treatment of hypertensive patients with diabetes: beyond blood pressure control and focus on manidipine. Future Cardiology 2016; 12(4): 435 doi: 10.2217/fca-2016-0027
|
| 9 |
Yoshio Ogura, Munehiro Kitada, Jing Xu, Itaru Monno, Daisuke Koya. CD38 inhibition by apigenin ameliorates mitochondrial oxidative stress through restoration of the intracellular NAD+/NADH ratio and Sirt3 activity in renal tubular cells in diabetic rats. Aging 2020; 12(12): 11325 doi: 10.18632/aging.103410
|
| 10 |
Munehiro Kitada, Shin-ichi Tsuda, Kazunori Konishi, Ai Takeda-Watanabe, Mizue Fujii, Keizo Kanasaki, Makoto Nishizawa, Atsushi Nakagawa, Daisuke Koya. Anagliptin ameliorates albuminuria and urinary liver-type fatty acid-binding protein excretion in patients with type 2 diabetes with nephropathy in a glucose-lowering-independent manner. BMJ Open Diabetes Research & Care 2017; 5(1): e000391 doi: 10.1136/bmjdrc-2017-000391
|
| 11 |
Maria L Ceretta, Marlies Noordzij, Rosario Luxardo, Johan De Meester, Jose M Abad Diez, Patrik Finne, James G Heaf, Cécile Couchoud, Reinhard Kramar, Frederic Collart, Aleix Cases, Runolfur Palsson, Anna V Reisæter, Helena Rydell, Ziad A Massy, Kitty J Jager, Anneke Kramer. Changes in co-morbidity pattern in patients starting renal replacement therapy in Europe—data from the ERA-EDTA Registry. Nephrology Dialysis Transplantation 2018; 33(10): 1794 doi: 10.1093/ndt/gfx355
|
| 12 |
Qian Luo, Yuzi Cai, Qihan Zhao, Lei Tian, Yuning Liu, Wei jing Liu. Effects of allopurinol on renal function in patients with diabetes: a systematic review and meta-analysis. Renal Failure 2022; 44(1): 806 doi: 10.1080/0886022X.2022.2068443
|
| 13 |
Munehiro Kitada, Yoshio Ogura, Itaru Monno, Daisuke Koya. Regulating Autophagy as a Therapeutic Target for Diabetic Nephropathy. Current Diabetes Reports 2017; 17(7) doi: 10.1007/s11892-017-0879-y
|
| 14 |
Munehiro Kitada, Taro Hirai, Daisuke Koya. Significance of SGLT2 inhibitors: lessons from renal clinical outcomes in patients with type 2 diabetes and basic researches. Diabetology International 2020; 11(3): 245 doi: 10.1007/s13340-020-00444-8
|
| 15 |
Meghan M. Kiefer, Michael J. Ryan. Primary Care of the Patient with Chronic Kidney Disease. Medical Clinics of North America 2015; 99(5): 935 doi: 10.1016/j.mcna.2015.05.003
|
| 16 |
Weihuang Zhang, Xiaoyu Li, Shujun Wang, Yanse Chen, Huafeng Liu. Regulation of TFEB activity and its potential as a therapeutic target against kidney diseases. Cell Death Discovery 2020; 6(1) doi: 10.1038/s41420-020-0265-4
|
| 17 |
Kim Anne Pickett. Microvascular Complications of Diabetes: What’s Relevant for Practice?. The Journal for Nurse Practitioners 2016; 12(10): 683 doi: 10.1016/j.nurpra.2016.08.012
|
| 18 |
Reham Hussein Mohamed, Amina Ahmed Sedky, Ghada Galal Hamam, Lobna Elkhateb, Sherif A. Kamar, Seham Adel, Sherin Shafik Tawfik. Sitagliptin's renoprotective effect in a diabetic nephropathy model in rats: The potential role of PI3K/AKT pathway. Fundamental & Clinical Pharmacology 2022; 36(2): 324 doi: 10.1111/fcp.12736
|
| 19 |
Jisu Park, Eunhui Seo, Hee-Sook Jun. Bavachin alleviates diabetic nephropathy in db/db mice by inhibition of oxidative stress and improvement of mitochondria function. Biomedicine & Pharmacotherapy 2023; 161: 114479 doi: 10.1016/j.biopha.2023.114479
|
| 20 |
Munehiro Kitada, Yoshio Ogura, Taeko Suzuki, Itaru Monno, Keizo Kanasaki, Ai Watanabe, Daisuke Koya. A low-protein diet exerts a beneficial effect on diabetic status and prevents diabetic nephropathy in Wistar fatty rats, an animal model of type 2 diabetes and obesity. Nutrition & Metabolism 2018; 15(1) doi: 10.1186/s12986-018-0255-1
|
| 21 |
G. Michelle Ducasa, Alla Mitrofanova, Shamroop K. Mallela, Xiaochen Liu, Judith Molina, Alexis Sloan, Christopher E. Pedigo, Mengyuan Ge, Javier Varona Santos, Yanio Hernandez, Jin-Ju Kim, Cyrille Maugeais, Armando J. Mendez, Viji Nair, Matthias Kretzler, George W. Burke, Robert G. Nelson, Yu Ishimoto, Reiko Inagi, Santanu Banerjee, Shaoyi Liu, Hazel H. Szeto, Sandra Merscher, Flavia Fontanesi, Alessia Fornoni. ATP-binding cassette A1 deficiency causes cardiolipin-driven mitochondrial dysfunction in podocytes. Journal of Clinical Investigation 2019; 129(8): 3387 doi: 10.1172/JCI125316
|
| 22 |
Jinghua Sun, Juanjuan Han, Jie Dong, Xiaoyan Zhai, Ruiping Zhang. A kidney-targeted chitosan-melanin nanoplatform for alleviating diabetic nephropathy through modulation of blood glucose and oxidative stress. International Journal of Biological Macromolecules 2024; 264: 130663 doi: 10.1016/j.ijbiomac.2024.130663
|
| 23 |
Mohammad Hassan Sohouli, Parvin Mirmiran, Shaikh Sanjid Seraj, Emad Kutbi, Hadil Ali Mohammed Alkahmous, Faisal Almuqayyid, Omar Ahnaf Arafah, Abdul Rahman Riad Barakeh, Ahmed Abu-Zaid. Impact of low-protein diet on cardiovascular risk factors and kidney function in diabetic nephropathy: A systematic review and meta-analysis of randomized-controlled trials. Diabetes Research and Clinical Practice 2022; 191: 110068 doi: 10.1016/j.diabres.2022.110068
|
| 24 |
Munehiro Kitada, Yoshio Ogura, Kyoko Nitta, Mizue Fujii, Keizo Kanasaki, Kazunori Konishi, Yasuo Iida, Atsushi Nakagawa, Daisuke Koya. Effect of switching to teneligliptin from other dipeptidyl peptidase‐4 inhibitors on glucose control and renoprotection in type 2 diabetes patients with diabetic kidney disease. Journal of Diabetes Investigation 2019; 10(3): 706 doi: 10.1111/jdi.12917
|
| 25 |
Mi-Kyung Kim. Treatment of diabetic kidney disease: current and future targets. The Korean Journal of Internal Medicine 2017; 32(4): 622 doi: 10.3904/kjim.2016.219
|
| 26 |
Yunqian Wang, Lei Xue, Huicong Li, Jun Shi, Baoping Chen. Knockdown of FOXO6 inhibits cell proliferation and ECM accumulation in glomerular mesangial cells cultured under high glucose condition. RSC Advances 2019; 9(3): 1741 doi: 10.1039/C8RA10547B
|
| 27 |
Munehiro Kitada, Yoshio Ogura, Itaru Monno, Daisuke Koya. A Low-Protein Diet for Diabetic Kidney Disease: Its Effect and Molecular Mechanism, an Approach from Animal Studies. Nutrients 2018; 10(5): 544 doi: 10.3390/nu10050544
|
| 28 |
Shelagh M. Szabo, Katherine M. Osenenko, Lara Qatami, Bonnie M. Korenblat Donato, Ellen E. Korol, Abdulrazzaq A. Al Madani, Fatheya F. Al Awadi, Jaber Al-Ansari, Ross Maclean, Adrian R. Levy. Quality of Care for Patients with Type 2 Diabetes Mellitus in Dubai: A HEDIS-Like Assessment. International Journal of Endocrinology 2015; 2015: 1 doi: 10.1155/2015/413276
|
| 29 |
Munehiro Kitada, Yoshio Ogura, Taeko Suzuki, Itaru Monnno, Keizo Kanasaki, Ai Watanabe, Daisuke Koya. Cyclic and intermittent very low‐protein diet can have beneficial effects against advanced diabetic nephropathy in Wistar fatty (fa/fa) rats, an animal model of type 2 diabetes and obesity. Nephrology 2017; 22(12): 1030 doi: 10.1111/nep.13152
|
| 30 |
Alaa Abou Daher, Sahar Alkhansa, William S. Azar, Rim Rafeh, Hilda E. Ghadieh, Assaad A. Eid. Translational Aspects of the Mammalian Target of Rapamycin Complexes in Diabetic Nephropathy. Antioxidants & Redox Signaling 2022; 37(10-12): 802 doi: 10.1089/ars.2021.0217
|
| 31 |
Bin Li, Yanan Zhu, Haiyun Chen, Hui Gao, Hangyuan He, Na Zuo, Linguo Pei, Wen Xie, Liaobin Chen, Ying Ao, Hui Wang. Decreased H3K9ac level of AT2R mediates the developmental origin of glomerulosclerosis induced by prenatal dexamethasone exposure in male offspring rats. Toxicology 2019; 411: 32 doi: 10.1016/j.tox.2018.10.013
|
| 32 |
Munehiro Kitada, Yoshio Ogura, Taeko Suzuki, Shi Sen, Seon Myeong Lee, Keizo Kanasaki, Shinji Kume, Daisuke Koya. A very-low-protein diet ameliorates advanced diabetic nephropathy through autophagy induction by suppression of the mTORC1 pathway in Wistar fatty rats, an animal model of type 2 diabetes and obesity. Diabetologia 2016; 59(6): 1307 doi: 10.1007/s00125-016-3925-4
|
| 33 |
Martin Ho Yin Yeung, Ka Long Leung, Lai Yuen Choi, Jung Sun Yoo, Susan Yung, Pui-Kin So, Chi-Ming Wong. Lipidomic Analysis Reveals the Protection Mechanism of GLP-1 Analogue Dulaglutide on High-Fat Diet-Induced Chronic Kidney Disease in Mice. Frontiers in Pharmacology 2022; 12 doi: 10.3389/fphar.2021.777395
|
| 34 |
Efficacy of low-protein diet for diabetic nephropathy: a systematic review of randomized controlled trials. Lipids in Health and Disease 2018; 17(1) doi: 10.1186/s12944-018-0791-8
|
| 35 |
Xuemei Liu, Deliang Liu, Youyou Shuai, Huilin Li, Hengxia Zhao, Xin Qu, Shufang Chu, Xuewen Zhang. Effects of HuoxueJiangtang decoction alone or in combination with metformin on renal function and renal cortical mRNA expression in diabetic nephropathy rats. Pharmaceutical Biology 2020; 58(1): 1132 doi: 10.1080/13880209.2020.1844242
|